Moderna, Inc.

Home » Moderna, Inc.

IPO

Moderna, Inc.

We are creating a new category of transformative medicines based on messenger RNA, or mRNA, to improve the lives of patients. From the beginning, we designed our strategy and operations to realize the full potential value and impact of mRNA over a long time horizon across a broad array of human diseases.

Symbol

MRNA

Final Price
$23.00

Final Shares
26

Effective Date
December 7, 2018

Underwriters
Morgan Stanley, Goldman Sachs & Co. LLC, J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray, Bryan, Garnier & Co., Oddo BHF, Oppenheimer & Co., Needham & Company, Chardan

To view the prospectus for Moderna, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253